Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -104.56M | -130.77M | -121.00M | -192.52M | -162.71M |
| Total Depreciation and Amortization | 58.54M | 60.47M | 60.27M | 58.86M | 58.02M |
| Total Amortization of Deferred Charges | 1.19M | 1.19M | 1.45M | 1.80M | 2.16M |
| Total Other Non-Cash Items | 24.61M | 19.52M | 8.84M | 112.21M | 105.56M |
| Change in Net Operating Assets | -19.30M | -7.98M | 1.01M | -1.51M | 3.52M |
| Cash from Operations | -39.52M | -57.57M | -49.44M | -21.16M | 6.54M |
| Capital Expenditure | -12.35M | -12.42M | -16.15M | -21.82M | -28.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -362.00K | -18.99M | -18.99M | -18.99M | -18.63M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 918.00K | 550.00K | 3.92M |
| Cash from Investing | -12.71M | -31.41M | -34.22M | -40.26M | -43.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.26M | -5.26M | -234.33M | -234.29M | -234.25M |
| Issuance of Common Stock | 4.73M | 4.73M | 1.60M | 1.49M | 1.48M |
| Repurchase of Common Stock | -- | -- | -- | -19.00K | -47.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.30M | -15.97M | -18.15M | -9.00M | -7.24M |
| Cash from Financing | -66.83M | -16.50M | -250.87M | -241.81M | -240.05M |
| Foreign Exchange rate Adjustments | -75.00K | -32.00K | -46.00K | -38.00K | 73.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.13M | -105.51M | -334.58M | -303.26M | -276.64M |